Next Article in Journal
The Adrenergic Receptor Antagonist Carvedilol Elicits Anti-Tumor Responses in Uveal Melanoma 3D Tumor Spheroids and May Serve as Co-Adjuvant Therapy with Radiation
Previous Article in Journal
Humanized Ovarian Cancer Patient-Derived Xenografts for Improved Preclinical Evaluation of Immunotherapies
Previous Article in Special Issue
Psychosocial Determinants of Lifestyle Change after a Cancer Diagnosis: A Systematic Review of the Literature
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cancers
Volume 14
Issue 13
10.3390/cancers14133096
cancers-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Pre-Diagnosis Diet and Physical Activity and Risk of Cardiovascular Disease Mortality among Female Cancer Survivors

by
Daphne Weikart
1,
Dan Lin
2,
Radha Dhingra
2,
Laila Al-Shaar
2 and
Kathleen Sturgeon
2,*
1
Department of Food Science, The Pennsylvania State University, University Park, PA 16802, USA
2
Department of Public Health Sciences, The Pennsylvania State University, Hershey, PA 17033, USA
*
Author to whom correspondence should be addressed.
Cancers 2022, 14(13), 3096; https://doi.org/10.3390/cancers14133096
Submission received: 6 May 2022 / Revised: 18 June 2022 / Accepted: 21 June 2022 / Published: 23 June 2022
(This article belongs to the Special Issue The Role of Lifestyle-Related Factors in Cancer Survivorship)
Browse Figure
Versions Notes

Abstract

:

Simple Summary

The number of cancer survivors is increasing; however, cancer survivors are at an increased risk of cardiovascular diseases (CVD) and CVD mortality. Therefore, it is pertinent to understand how lifestyle choices such as dietary patterns and physical activity are associated with this risk. Little is known about the relationship of pre-cancer diagnosis diet quality and physical activity (PA) with CVD among cancer survivors. Most studies have focused on post-cancer diagnosis risk factors, without accounting for their status in the pre-diagnosis period or interaction on CVD mortality. We examined pre-cancer diagnosis diet quality and physical activity in relation with CVD mortality risk in female cancer survivors from the California Teachers Study cohort. We hypothesized that higher diet quality scores and higher physical activity levels prior to cancer diagnosis would be associated with lower risk of CVD mortality in female cancer survivors.

Abstract

Sub-optimal diet and physical activity (PA) levels have been associated with increased risk of cardiovascular disease (CVD) mortality. The relationship between pre-cancer diagnosis diet quality and PA level on CVD mortality risk in cancer survivors is unclear. We examined the association between pre-cancer diagnosis diet quality and leisure-time PA and their interaction on CVD mortality in cancer survivors. Diet quality was characterized by the Alternative Mediterranean Diet Index (aMED). Leisure-time PA was converted to a metabolic equivalent of task hours per week (MET-h/wk). During a median of 6.3 years of follow-up of 18,533 female cancer survivors, we identified 915 CVD deaths. aMED score was not associated with CVD mortality. PA level was inversely associated with CVD mortality (HRQ1-Q4 = 0.74; 95% CI: 0.61–0.88; Ptrend = 0.0014). Compared to cancer survivors with the lowest pre-diagnosis aMED score and PA level, cancer survivors with higher aMED scores and higher MET-hrs/wk were at a 33% lower risk of CVD mortality (HR = 0.67; 95% CI: 0.52–0.87). Overall, this study shows PA to be a strong predictor of CVD mortality in female cancer survivors. Our observations support the importance of PA throughout the lifecycle in lowering CVD mortality risk.

1. Introduction

It is estimated that there are about 16.9 million cancer survivors in the US, and this number is expected to rise to over 20 million by 2030 [1]. With earlier detection of cancer and improved treatment protocols and therapies, the number of cancer survivors is increasing [2]. Cancer survivors face additional health consequences, as previous research has shown that cancer survivors are at a higher risk of cardiovascular disease (CVD) mortality compared to the general population [3,4]. In addition, heart disease is the leading cause of death among women in the US [5]. Women are less likely to receive preventive treatment or guidance in reducing risk factors than men at similar risk [6]. Women also tend to have less specific symptoms of heart disease than men, such as nausea, fatigue, or shortness of breath, making detection more difficult [7]. To understand the risk of CVD mortality, especially in an at-risk population such as female cancer survivors, it is important to understand the role of preventive lifestyle behaviors, such as diet and physical activity (PA) [8,9,10,11].
Poor diet and low PA levels are independently associated with higher risk for cancer and CVD mortality [8,9,10,11]. To prevent and manage chronic diseases, nutritional scientists have developed different indices to quantify a healthful diet. One such index is the Alternative Mediterranean Diet Index (aMED). Higher adherence to the Mediterranean diet includes higher intake of fish, fruits, vegetables, nuts, legumes, and whole grains instead of refined grains, and lower consumption of alcohol and red/processed meat. The Mediterranean dietary pattern has been associated with lower CV morbidity and mortality risks as well as improvement in CVD risk factors [12]. However, the literature examining the relationship between diet quality and CVD mortality in cancer survivors is scarce, as most of the literature has focused on cancer-specific and all-cause mortality outcomes [13,14,15,16,17,18,19,20,21,22]. With the increased risk of CVD in cancer survivors, it is important to know if this extends to CVD mortality.
Physical activity is also important in primary and secondary prevention of chronic diseases such as CVD. Higher PA levels have been associated with lower risk of CVD incidence and mortality [11]. The American Heart Association (AHA) and the American Cancer Society currently recommend adults get at least 7.5 MET-hrs/wk, preferably spread throughout the week [23,24]. Similar to studies assessing the role of diet in cancer, investigations of exercise and CVD risk in cancer survivors have focused on post-cancer diagnosis PA [25,26,27]. These studies did not address pre-cancer diagnosis PA or its change from before to after cancer diagnosis.
In this study, we investigated the association of pre-cancer diagnosis diet quality and PA level with risk of CVD mortality after cancer diagnosis. We hypothesized that a higher aMED score and higher PA level prior to cancer diagnosis would be associated with lower risk of CVD mortality in female cancer survivors. To our knowledge, no previous investigation has assessed pre-diagnosis diet quality and PA level or their interaction with CVD mortality in female survivors of all cancer types. The results of our study will inform primary care physicians and cardiologists as to the relative benefit a healthy lifestyle prior to a cancer diagnosis may have on risk for CVD mortality when determining prevention and treatment methods in cancer survivors.

2. Materials and Methods

2.1. Study Population

The California Teachers Study (CTS) is an ongoing prospective cohort study of 133,477 women that are active and retired public school teachers/administrators that completed a 16-page mailed questionnaire in 1995–1996 (questionnaire 1) [28]. This detailed questionnaire consisted of questions regarding possible risk factors for cancer including, but not limited to, body mass index (BMI), medications, diet, PA, alcohol intake, menopausal status, and smoking. Follow-up questionnaires were mailed in 1997–1998, 2000–2001, 2005–2006, 2012–2015 and, 2017–2019 for updates. Participants were included in the analysis if they had no history of cancer diagnosis, stroke or heart attack at baseline. Participants were excluded if they (1) had discrepancies that made their baseline questionnaires unusable, (2) did not live in California at baseline, (3) had missing variables in the food frequency questionnaire (FFQ) and total energy intake less than 600 kilocalories per day or above 3500 kilocalories per day, (4) had missing values for the leisure-time PA variable at baseline, or (5) were diagnosed with cancer one year following questionnaire 1. This secondary analysis of the CTS included 18,533 female cancer survivors. The use of this dataset for analysis was approved by the institutional review boards (IRBs) at The Pennsylvania State University (Hershey, PA, USA) and the City of Hope (Duarte, CA, USA).

2.2. Diet and Physical Activity Assessment

A detailed description of the dietary assessment has been published elsewhere [29]. Briefly, a 103-item, semiquantitative, validated FFQ [30] was completed as part of questionnaire 1 and questionnaire 4 to assess the dietary intake of participants in the past year. Participants indicated their frequency of consumption (categories ranged from never to once/day or 5+/day depending on the item) and portion size (small, medium or large relative to a given standard medium portion for questionnaire 1 and based on pictures using cup sizes for questionnaire 4). For computation of aMED for questionnaire 1, we used an index described previously [29] with nuts and legumes as separate categories. The aMED score for questionnaire 4 was calculated with the same food items that were consistent with questionnaire 1. For alcohol intake, ounces of alcohol consumed of each alcoholic beverage were calculated as the product of the reported intake based on specific drink size in ounces and the frequency of intake, multiplied by the respective percentage of alcohol included in each beverage (4.8% for beer; 12% for wine; 40% for liquor). The total amount was then multiplied by a factor of 28.3 to convert ounces/day to grams/day. A higher aMED score represents higher adherence to a Mediterranean diet, with the highest possible score being 9.
PA level was assessed based on questions regarding leisure-time PA level in questionnaire 1 and questionnaire 4. Participants reported whether they engaged in moderate exercises (e.g., brisk walking, golf, and volleyball) and strenuous exercises (e.g., swimming laps, aerobics, calisthenics, running, and jogging) in the past 3 years, and the frequency. Score of metabolic equivalent of task (MET) was assigned to standardize PA intensity using the 2011 Compendium of Physical Activities [31]. Moderate and strenuous exercise were assigned a score of 4.5 and 7.0 METs, respectively.

2.3. Outcomes

Cancer survivors were identified by using the date of diagnosis from any cancer, except non-melanoma skin cancer, through linkage of the CTS with the California Cancer Registry records [28,32], a mandated, statewide, population-based cancer reporting system. CVD mortality was defined based on the date-appropriate International Classification of Diseases (ICD), Ninth Revision codes 390–459 (through September 2015) or Tenth Revision codes I00-I99 (October 2015 and forward), through linkage with California mortality files, the Social Security Death Index, and the National Death Index records.

2.4. Statistical Analysis

Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated using multivariable Cox proportional hazards regression models with number of years since cancer diagnosis as the time scale. Person-time was calculated from the date of cancer diagnosis until (1) date of death, (2) they moved out of California for more than 4 consecutive months, or (3) 31 December 2017, whichever came first. aMED scores and PA MET-hours/week were ranked into quintiles and quartiles, respectively, with the lowest categories serving as the reference groups.
Baseline characteristics were standardized by age except age of participants and age at cancer diagnosis. Multivariable Cox regression models adjusted for the time interval from baseline to cancer diagnosis date and age at cancer diagnosis (model 1), in addition to race, smoking status, menopausal status and hormone use, total energy intake, and daily vitamin use (model 2). Further adjustments were made after including either PA for the analysis of diet quality (model 3) or aMED scores for the analysis of PA (model 4). To reduce potential bias from reverse causation and disease severity, sensitivity analyses were performed after restricting the analysis to female cancer survivors who had their dietary and PA data collected in questionnaire 4, at least one year after their cancer diagnosis date. These analyses of the association of pre-cancer diagnosis aMED scores and PA were adjusted for post-diagnosis aMED scores and PA, respectively. Due to the small number of cancer survivors with available data in both questionnaires 1 and 4, aMED scores and PA variables were analyzed as tertiles. Additionally, a post hoc power analysis was conducted.
Interaction between aMED score and PA level was assessed by using these two variables as indicator variables. Specifically, the -2log likelihood ratio (−2 LL) test was conducted to compare the differences between the full model with interaction terms and the reduced one without interaction terms. Trend tests were conducted by assigning median values for each category as a continuous variable. All statistical analyses were conducted in SAS 9.4 (Cary, NC, USA) in the CTS’s secure shared workspace [33]. Statistical significance was defined as a two-sided p value < 0.05.

3. Results

A total of 18,533 female cancer survivors were included in this study, of whom 40.9% had breast cancer, 10.6% melanoma of the skin, 6.6% uterine cancer, 5.5% lung cancer, and 36.4% another type of cancer. Table 1 shows the age-adjusted characteristics for the study population by quintiles of the aMED score. Participants with higher aMED scores were older, more physically active, less likely to be obese, had higher alcohol and total energy intake, had daily vitamin consumption, and were more likely to have a late-life cancer diagnosis. Participants with higher PA levels were associated with lower BMI, greater alcohol use, daily vitamin consumption, and were more likely to be white (Supplemental Table S1). These participants were also less likely to be smokers or have a history of diabetes or hypertension.
During a median time of 6.3 years of follow-up, we identified 915 CVD deaths. No significant association was observed between the aMED score and CVD mortality, as shown in Table 2. Pre-cancer diagnosis PA level was inversely associated with risk of CVD mortality, and the inverse association remained significant after the simultaneous adjustment for diet quality (Table 2; Model 4: Ptrend = 0.0014). Compared to the lowest quartile, female cancer survivors with 13.5-<27.5 MET-hrs/wk of PA prior to cancer diagnosis had a 20% lower risk of CVD mortality (Model 4: HRQ1-Q3 = 0.80; 95% CI: 0.67–0.96). Female cancer survivors with pre-cancer diagnosis PA levels of ≥27.5 MET-hrs/wk also had lower risk of CVD mortality (Model 4: HRQ1-Q4 = 0.74; 95% CI:0.61, 0.88).
Despite no significant interaction between pre-cancer diagnosis aMED and PA in relation to CVD mortality, the joint association of diet and PA showed lower CVD mortality risk among those who had higher PA levels and aMED scores (Figure 1). Compared to those with the lowest levels of pre-diagnosis aMED scores and PA, cancer survivors with the highest levels of PA had 32% and 33% lower risk of CVD mortality when their aMED score was ≥6 (HR = 0.67; 95% CI: 0.52–0.87) or between 4 and 6, respectively; HR = 0.68 (0.52, 0.90). (Supplemental Table S2; Model 2: Pinteraction = 0.13).
Sensitivity analyses to account for post-diagnosis aMED scores and PA was conducted (Table 3). These associations with CVD mortality risk were no longer significant after adjusting for post-cancer diagnosis data. This may be due to a smaller sample size and converting to tertiles because of small sample size. Post hoc power analysis showed 50% and 76% power to detect a significant association of the aMED and PA level with CVD mortality, respectively.

4. Discussion

Previous research has shown an increased risk of CVD in cancer survivors compared to the general population [3,4]. With this increased risk of CVD, and a parallel growth in cancer survivors, the importance of lifestyle factors before cancer diagnosis in assessing risk of CVD mortality in cancer survivors helps inform clinicians in cardio-oncology. This secondary analysis investigated the association between pre-cancer diagnosis diet quality and PA level and their interaction on CVD mortality in female cancer survivors. We did not find a significant association between aMED score and CVD mortality, but we did find a significant inverse relationship between leisure-time PA level prior to cancer diagnosis and CVD mortality in this population. We observed that regardless of the aMED score, a higher PA activity level was a stronger predictor for CVD mortality.
When looking at the characteristics of this population based on the aMED score, higher scores were associated with older participants. A possible explanation for this is having more time available to focus on eating habits in lieu of parenthood and job responsibilities. If individuals were older when they participated and had no history of cancer diagnosis, they would also be older when they were diagnosed with cancer. Individuals with higher aMED scores could also be more health conscious, which may further explain their lower BMIs and higher PA levels. Higher energy intake was also associated with higher aMED scores, which may seem counter-intuitive because higher aMED scores were associated with lower BMI; however, the highest energy intake quartile was, on average, still below 2000 kilocalories, and these participants also had higher PA levels which may balance energy intake and expenditure.
Previous work has shown an inverse association between diet quality and all-cause mortality in cancer survivors [16,17,34,35]. These studies did not explore the specific relationship between pre-diagnosis diet quality and CVD mortality in cancer survivors. To our knowledge, this relationship has not been investigated in this cohort. We assessed the risk of death from CVD based on the aMED score in this population and found no significant association between the pre-cancer diagnosis aMED score and CVD mortality risk. It is possible that a different dietary index would be a stronger predictor of CVD mortality in this population, such as the Alternative Healthy Eating Index (AHEI) which has been shown to decrease CVD mortality risk [36]. However, because the amount of dietary trans fat and omega-3 fatty acids were not available for the CTS cohort, we could not calculate AHEI scores.
We also estimated CVD mortality risk based on pre-diagnosis PA and found an inverse association between pre-diagnosis PA level and CVD mortality. PA was associated with up to 20% lower CVD mortality risk for participants with PA levels of 27.5 MET hrs/wk or more. A total of 27.5 MET hrs/wk is equivalent to running (~9 METs) for an hour 3 times a week or taking a walk (~4 METs) for an hour every day of the week. Lower CVD mortality risk was also seen among participants with PA levels ranging between 13.5 MET hrs/wk and 27.5 MET hrs/wk. For example, 15 MET hrs/wk could be attained with moderate-intensity exercise (~5 METs) for 3 times a week. Thus, independent of aMED score, a PA level approximately twice the current PA recommendations (7.5 MET hrs/wk), prior to cancer diagnosis, could reduce CVD mortality risk in cancer survivors. Previous work has reported post-cancer diagnosis adherence to the American Cancer Society PA guidelines (7.5 MET hrs/wk) was associated with lower risk of CVD mortality among cancer survivors [37].
Since PA and diet are important lifestyle behaviors related to CVD mortality, we tested their interaction and no statistical significance was observed. However, a higher PA level was associated with lower CVD mortality risk in both aMED score categories (4-<6 and ≥6). There is very little research on the interaction between diet quality and PA on CVD mortality in cancer survivors. One study showed that higher post-cancer diagnosis aMED scores were associated with lower risk of non-breast cancer mortality in women with low PA [18], but CVD mortality was not investigated among these cancer patients.
A strength of our study is the mitigation of reverse causality bias. Cancer survivors can experience many symptoms, such as fatigue and nausea, which may affect diet quality and PA level [38,39]. To avoid biased estimates of the changes of PA levels from before to after cancer diagnosis that could be due to disease symptoms and its severity, questionnaires collected after a year from cancer diagnosis were only included. Unfortunately, we did not have enough power to adequately address this concern; however, it appears that adjusting for post-diagnosis PA level made the associations between pre-cancer diagnosis PA level and risk for CVD mortality weaker.
There are some limitations to our study. The first is that only one dietary index was used and portion sizes for the FFQ in questionnaire 1 and in questionnaire 4 were different. Questionnaire 1 FFQ used small, medium, and large portions, whereas questionnaire 4 FFQ was based on pictures of cup sizes for participants to determine their portions. Moreover, there was a ten-year difference between these questionnaires. Thus, changes in reporting of portion sizes is reflective of changes in cultural norms related to portion size [40]. However, aMED scores were calculated separately in each questionnaire cycle, and participants were then ranked to each other. Another limitation is that we did not have enough statistical power to stratify associations by cancer type. When stratified by cancer type, power dropped down to 40% for diet and 73% for PA. Given the limited power for cancer type, we could not additionally stratify CVD mortality risk based on cancer treatment. This is a limitation, as there are several cancer types for which there are many different treatment options, with some having higher risk for CVD mortality [41].

5. Conclusions

This is the first study to examine the relationship between diet quality and PA prior to cancer diagnosis and their interaction on CVD mortality in female cancer survivors. Research in this area is scarce and more work is needed to confirm the relationship between pre-diagnosis diet quality and PA and their interaction on CVD mortality in other populations. Overall, this study showed an inverse association between pre-cancer diagnosis PA level and CVD mortality in female cancer survivors. This relationship was no longer significant when adjusting for post-diagnosis PA level (however, this model was underpowered). Nonetheless, our observations support the importance of PA throughout the lifecycle in decreasing risk of CVD mortality. Primary care physicians (PCPs) should continue to relay the significance of PA level in their healthy patients prior to a potential diagnosis of cancer and follow the recommendations of the AHA and ACS. Additionally, it is important for clinicians to recognize that a cancer survivor who had high PA levels prior to their cancer diagnosis may have decreased risk for CVD mortality during cancer survivorship.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/cancers14133096/s1, Table S1: Age adjusted characteristics of female cancer survivors in the California Teachers Study cohort by quartiles of the pre-cancer diagnosis Metabolic Equivalent Task Scores; Table S2: HRs (95% CIs) for association between aMED, physical activity, and CVD death.

Author Contributions

D.W. helped with conceptualization, methodology, and wrote the original draft for this work. D.L. helped with methodology, data curation, and editing. R.D. helped with data curation for questionnaire 4 aMED scores and editing. L.A.-S. helped with conceptualization, methodology, editing, and co-supervised. K.S. helped with conceptualization, methodology, editing, and co-supervised. All authors have read and agreed to the published version of the manuscript.

Funding

The California Teachers Study and the research reported in this publication were supported by the National Cancer Institute of the National Institutes of Health under award number U01-CA199277; P30-CA033572; P30-CA023100; UM1-CA164917; and R01-CA077398.

Institutional Review Board Statement

The study was conducted in accordance with the Declaration of Helsinki, and approved by the Institutional Review Board of The Pennsylvania State University (protocol STUDY00018265 approved 09/01/2021).

Informed Consent Statement

Informed consent was obtained from all subjects involved in the study.

Data Availability Statement

The datasets analyzed for this study can be found in the California Teachers Study: https://www.calteachersstudy.org/cts-data (accessed on 15 February 2022).

Acknowledgments

The California Teachers Study and the research reported in this publication were supported by the National Cancer Institute of the National Institutes of Health under award number U01-CA199277; P30-CA033572; P30-CA023100; UM1-CA164917; and R01-CA077398. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The collection of cancer incidence data used in the California Teachers Study was supported by the California Department of Public Health pursuant to California Health and Safety Code Section 103885; Centers for Disease Control and Prevention’s National Program of Cancer Registries, under cooperative agreement 5NU58DP006344; the National Cancer Institute’s Surveillance, Epidemiology and End Results Program under contract HHSN261201800032I awarded to the University of California, San Francisco, contract HHSN261201800015I awarded to the University of Southern California, and contract HHSN261201800009I awarded to the Public Health Institute. The opinions, findings, and conclusions expressed herein are those of the author(s) and do not necessarily reflect the official views of the State of California, Department of Public Health, the National Cancer Institute, the National Institutes of Health, the Centers for Disease Control and Prevention or their Contractors and Subcontractors, or the Regents of the University of California, or any of its programs. The authors would like to thank the California Teachers Study Steering Committee that is responsible for the formation and maintenance of the study within which this research was conducted. A full list of California Teachers Study team members is available at: https://www.calteachersstudy.org/team (accessed on 15 February 2022).

Conflicts of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. National Center Institute. Cancer Statistics. Available online: https://www.cancer.gov/about-cancer/understanding/statistics (accessed on 14 December 2021).
  2. Siegel, R.L.; Miller, K.D.; Jemal, A. Cancer statistics, 2019. CA Cancer J. Clin. 2019, 69, 7–34. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Stoltzfus, K.C.; Zhang, Y.; Sturgeon, K.; Sinoway Lawrence, I.; Trifiletti, D.M.; Chinchilli, V.M.; Zaorsky, N.G. Fatal heart disease among cancer patients. Nat. Commun. 2020, 11, 2011. [Google Scholar] [CrossRef] [PubMed]
  4. Sturgeon, K.M.; Deng, L.; Bluethmann, S.M.; Zhou, S.; Trifiletti, D.M.; Jiang, C.; Kelly, S.P.; Zaorsky, N.G. A population-based study of cardiovascular disease mortality risk in US cancer patients. Eur. Heart J. 2019, 40, 3889–3897. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Cushman, M.; Shay, C.M.; Howard, V.J.; Jiménez, M.C.; Lewey, J.; McSweeney, J.C.; Newby, L.K.; Poudel, R.; Reynolds, H.R.; Rexrode, K.M.; et al. Ten-Year Differences in Women’s Awareness Related to Coronary Heart Disease: Results of the 2019 American Heart Association National Survey: A Special Report From the American Heart Association. Circulation 2021, 143, e239–e248. [Google Scholar] [CrossRef] [PubMed]
  6. Garcia, M.; Mulvagh, S.L.; Merz, C.N.B.; Buring, J.E.; Manson, J.E. Cardiovascular Disease in Women: Clinical Perspectives. Circ. Res. 2016, 118, 1273–1293. [Google Scholar] [CrossRef]
  7. Keteepe-Arachi, T.; Sharma, S. Cardiovascular Disease in Women: Understanding Symptoms and Risk Factors. Eur. Cardiol. 2017, 12, 10–13. [Google Scholar] [CrossRef] [Green Version]
  8. Schwingshackl, L.; Schwedhelm, C.; Galbete, C.; Hoffmann, G. Adherence to Mediterranean Diet and Risk of Cancer: An Updated Systematic Review and Meta-Analysis. Nutrients 2017, 9, 1063. [Google Scholar] [CrossRef]
  9. Salas-Salvadó, J.; Becerra-Tomás, N.; García-Gavilán, J.F.; Bulló, M.; Barrubés, L. Mediterranean Diet and Cardiovascular Disease Prevention: What Do We Know? Prog. Cardiovasc. Dis. 2018, 61, 62–67. [Google Scholar] [CrossRef]
  10. Brown, J.C.; Winters-Stone, K.; Lee, A.; Schmitz, K.H. Cancer, physical activity, and exercise. Compr. Physiol. 2012, 2, 2775–2809. [Google Scholar] [CrossRef] [Green Version]
  11. Lavie, C.J.; Ozemek, C.; Carbone, S.; Katzmarzyk, P.T.; Blair, S.N. Sedentary Behavior, Exercise, and Cardiovascular Health. Circ. Res. 2019, 124, 799–815. [Google Scholar] [CrossRef]
  12. Widmer, R.J.; Flammer, A.J.; Lerman, L.O.; Lerman, A. The Mediterranean Diet, its Components, and Cardiovascular Disease. Am. J. Med. 2015, 128, 229–238. [Google Scholar] [CrossRef] [Green Version]
  13. Kroenke, C.H.; Fung, T.T.; Hu, F.B.; Holmes, M.D. Dietary Patterns and Survival After Breast Cancer Diagnosis. J. Clin. Oncol. 2005, 23, 9295–9303. [Google Scholar] [CrossRef]
  14. Kwan, M.L.; Weltzien, E.; Kushi, L.H.; Castillo, A.; Slattery, M.L.; Caan, B.J. Dietary Patterns and Breast Cancer Recurrence and Survival Among Women With Early-Stage Breast Cancer. J. Clin. Oncol. 2008, 27, 919–926. [Google Scholar] [CrossRef] [Green Version]
  15. Vrieling, A.; Buck, K.; Seibold, P.; Heinz, J.; Obi, N.; Flesch-Janys, D.; Chang-Claude, J. Dietary patterns and survival in German postmenopausal breast cancer survivors. Br. J. Cancer 2013, 108, 188–192. [Google Scholar] [CrossRef] [Green Version]
  16. George, S.M.; Ballard-Barbash, R.; Shikany, J.M.; Caan, B.J.; Freudenheim, J.L.; Kroenke, C.H.; Vitolins, M.Z.; Beresford, S.A.; Neuhouser, M.L. Better Postdiagnosis Diet Quality Is Associated with Reduced Risk of Death among Postmenopausal Women with Invasive Breast Cancer in the Women’s Health Initiative. Cancer Epidemiol. Biomark. Prev. 2014, 23, 575. [Google Scholar] [CrossRef] [Green Version]
  17. George, S.M.; Irwin, M.L.; Smith, A.W.; Neuhouser, M.L.; Reedy, J.; McTiernan, A.; Alfano, C.M.; Bernstein, L.; Ulrich, C.M.; Baumgartner, K.B.; et al. Postdiagnosis diet quality, the combination of diet quality and recreational physical activity, and prognosis after early-stage breast cancer. Cancer Causes Control 2011, 22, 589–598. [Google Scholar] [CrossRef] [Green Version]
  18. Kim, E.H.J.; Willett, W.C.; Fung, T.; Rosner, B.; Holmes, M.D. Diet Quality Indices and Postmenopausal Breast Cancer Survival. Nutr. Cancer 2011, 63, 381–388. [Google Scholar] [CrossRef] [Green Version]
  19. Pierce, J.P.; Natarajan, L.; Caan, B.J.; Parker, B.A.; Greenberg, E.R.; Flatt, S.W.; Rock, C.L.; Kealey, S.; Al-Delaimy, W.K.; Bardwell, W.A.; et al. Influence of a Diet Very High in Vegetables, Fruit, and Fiber and Low in Fat on Prognosis Following Treatment for Breast CancerThe Women’s Healthy Eating and Living (WHEL) Randomized Trial. JAMA 2007, 298, 289–298. [Google Scholar] [CrossRef]
  20. Chlebowski, R.T.; Aragaki, A.K.; Anderson, G.L.; Thomson, C.A.; Manson, J.E.; Simon, M.S.; Howard, B.V.; Rohan, T.E.; Snetselar, L.; Lane, D.; et al. Low-Fat Dietary Pattern and Breast Cancer Mortality in the Women’s Health Initiative Randomized Controlled Trial. J. Clin. Oncol. 2017, 35, 2919–2926. [Google Scholar] [CrossRef] [Green Version]
  21. Schwedhelm, C.; Boeing, H.; Hoffmann, G.; Aleksandrova, K.; Schwingshackl, L. Effect of diet on mortality and cancer recurrence among cancer survivors: A systematic review and meta-analysis of cohort studies. Nutr. Rev. 2016, 74, 737–748. [Google Scholar] [CrossRef] [Green Version]
  22. Friedenreich, C.M.; Stone, C.R.; Cheung, W.Y.; Hayes, S.C. Physical Activity and Mortality in Cancer Survivors: A Systematic Review and Meta-Analysis. JNCI Cancer Spectr. 2019, 4, pkz080. [Google Scholar] [CrossRef]
  23. Association, A.H. American Heart Association Recommendations for Physical Activity in Adults and Kids. Available online: https://www.heart.org/en/healthy-living/fitness/fitness-basics/aha-recs-for-physical-activity-in-adults (accessed on 11 October 2021).
  24. Rock, C.L.; Thomson, C.; Gansler, T.; Gapstur, S.M.; McCullough, M.L.; Patel, A.V.; Andrews, K.S.; Bandera, E.V.; Spees, C.K.; Robien, K.; et al. American Cancer Society guideline for diet and physical activity for cancer prevention. CA Cancer J. Clin. 2020, 70, 245–271. [Google Scholar] [CrossRef]
  25. Keats, M.R.; Cui, Y.; Grandy, S.A.; Parker, L. Cardiovascular disease and physical activity in adult cancer survivors: A nested, retrospective study from the Atlantic PATH cohort. J. Cancer Surviv. 2017, 11, 264–273. [Google Scholar] [CrossRef]
  26. Kim, K.H.; Choi, S.; Kim, K.; Chang, J.; Kim, S.M.; Kim, S.R.; Cho, Y.; Oh, Y.H.; Lee, G.; Son, J.S.; et al. Association between physical activity and subsequent cardiovascular disease among 5-year breast cancer survivors. Breast Cancer Res. Treat. 2021, 188, 203–214. [Google Scholar] [CrossRef]
  27. Jones, L.W.; Liu, Q.; Armstrong, G.T.; Ness, K.K.; Yasui, Y.; Devine, K.; Tonorezos, E.; Soares-Miranda, L.; Sklar, C.A.; Douglas, P.S.; et al. Exercise and Risk of Major Cardiovascular Events in Adult Survivors of Childhood Hodgkin Lymphoma: A Report From the Childhood Cancer Survivor Study. J. Clin. Oncol. 2014, 32, 3643–3650. [Google Scholar] [CrossRef]
  28. Bernstein, L.; Allen, M.; Anton-Culver, H.; Deapen, D.; Horn-Ross, P.L.; Peel, D.; Pinder, R.; Reynolds, P.; Sullivan-Halley, J.; West, D.; et al. High breast cancer incidence rates among California teachers: Results from the California Teachers Study (United States). Cancer Causes Control 2002, 13, 625–635. [Google Scholar] [CrossRef]
  29. Haridass, V.; Ziogas, A.; Neuhausen, S.L.; Anton-Culver, H.; Odegaard, A.O. Diet Quality Scores Inversely Associated with Postmenopausal Breast Cancer Risk Are Not Associated with Premenopausal Breast Cancer Risk in the California Teachers Study. J. Nutr. 2018, 148, 1830–1837. [Google Scholar] [CrossRef] [Green Version]
  30. Horn-Ross, P.L.; Lee, V.S.; Collins, C.N.; Stewart, S.L.; Canchola, A.J.; Lee, M.M.; Reynolds, P.; Clarke, C.A.; Bernstein, L.; Stram, D.O. Dietary assessment in the California Teachers Study: Reproducibility and validity. Cancer Causes Control 2008, 19, 595–603. [Google Scholar] [CrossRef] [Green Version]
  31. Ainsworth, B.E.; Haskell, W.L.; Herrmann, S.D.; Meckes, N.; Bassett, D.R.J.; Tudor-Locke, C.; Greer, J.L.; Vezina, J.; Whitt-Glover, M.C.; Leon, A.S. 2011 Compendium of Physical Activities: A Second Update of Codes and MET Values. Med. Sci. Sports Exerc. 2011, 43, 1575–1581. [Google Scholar] [CrossRef] [Green Version]
  32. California Cancer Registry. About California Cancer Registry. Available online: https://www.ccrcal.org/learn-about-ccr/about-cancer-registries/ (accessed on 15 February 2022).
  33. Lacey, J.V., Jr.; Chung, N.T.; Hughes, P.; Benbow, J.L.; Duffy, C.; Savage, K.E.; Spielfogel, E.S.; Wang, S.S.; Martinez, M.E.; Chandra, S. Insights from Adopting a Data Commons Approach for Large-scale Observational Cohort Studies: The California Teachers Study. Cancer Epidemiol. Biomark. Prev. 2020, 29, 777–786. [Google Scholar] [CrossRef] [Green Version]
  34. Zheng, J.; Tabung, F.K.; Zhang, J.; Murphy, E.A.; Shivappa, N.; Ockene, J.K.; Caan, B.; Kroenke, C.H.; Hébert, J.R.; Steck, S.E. Post-cancer diagnosis dietary inflammatory potential is associated with survival among women diagnosed with colorectal cancer in the Women’s Health Initiative. Eur. J. Nutr. 2020, 59, 965–977. [Google Scholar] [CrossRef] [PubMed]
  35. Karavasiloglou, N.; Pestoni, G.; Faeh, D.; Rohrmann, S. Post-Diagnostic Diet Quality and Mortality in Females with Self-Reported History of Breast or Gynecological Cancers: Results from the Third National Health and Nutrition Examination Survey (NHANES III). Nutrients 2019, 11, 2558. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  36. Akbaraly, T.N.; Ferrie, J.E.; Berr, C.; Brunner, E.J.; Head, J.; Marmot, M.G.; Singh-Manoux, A.; Ritchie, K.; Shipley, M.J.; Kivimaki, M. Alternative Healthy Eating Index and mortality over 18 y of follow-up: Results from the Whitehall II cohort. Am. J. Clin. Nutr. 2011, 94, 247–253. [Google Scholar] [CrossRef] [PubMed]
  37. Tarasenko, Y.N.; Linder, D.F.; Miller, E.A. Muscle-strengthening and aerobic activities and mortality among 3+ year cancer survivors in the U.S. Cancer Causes Control 2018, 29, 475–484. [Google Scholar] [CrossRef] [PubMed]
  38. Mattox, T.W. Cancer Cachexia: Cause, Diagnosis, and Treatment. Nutr. Clin. Pract. 2017, 32, 599–606. [Google Scholar] [CrossRef] [PubMed]
  39. Demark-Wahnefried, W.; Hars, V.; Conaway, M.R.; Havlin, K.; Rimer, B.K.; McElveen, G.; Winer, E.P. Reduced rates of metabolism and decreased physical activity in breast cancer patients receiving adjuvant chemotherapy. Am. J. Clin. Nutr. 1997, 65, 1495–1501. [Google Scholar] [CrossRef]
  40. Young, L.R.; Nestle, M. The contribution of expanding portion sizes to the US obesity epidemic. Am. J. Public Health 2002, 92, 246–249. [Google Scholar] [CrossRef]
  41. Gernaat, S.A.M.; Ho, P.J.; Rijnberg, N.; Emaus, M.J.; Baak, L.M.; Hartman, M.; Grobbee, D.E.; Verkooijen, H.M. Risk of death from cardiovascular disease following breast cancer: A systematic review. Breast Cancer Res. Treat. 2017, 164, 537–555. [Google Scholar] [CrossRef] [Green Version]
Cancers 14 03096 g001 550
Figure 1. Adjusted Hazard ratios (95% CI) of CVD mortality for the joint association between pre-cancer diagnosis Alternate Mediterranean Diet score and metabolic equivalent task hours per week score among female cancer survivors in the California Teachers Study cohort (n = 18,533). Adjusted for interval from questionnaire 1 to cancer diagnosis date, age at cancer diagnosis, race, smoking status, menopausal status and hormone use, total energy intake, and daily vitamin use. * Signifies significant difference (p < 0.05).
Figure 1. Adjusted Hazard ratios (95% CI) of CVD mortality for the joint association between pre-cancer diagnosis Alternate Mediterranean Diet score and metabolic equivalent task hours per week score among female cancer survivors in the California Teachers Study cohort (n = 18,533). Adjusted for interval from questionnaire 1 to cancer diagnosis date, age at cancer diagnosis, race, smoking status, menopausal status and hormone use, total energy intake, and daily vitamin use. * Signifies significant difference (p < 0.05).
Cancers 14 03096 g001
Table
Table 1. Age adjusted 1 characteristics of female cancer survivors in the California Teachers Study cohort by quintiles of the pre-cancer diagnosis Alternative Mediterranean Diet score (n = 18,533 participants).
Table 1. Age adjusted 1 characteristics of female cancer survivors in the California Teachers Study cohort by quintiles of the pre-cancer diagnosis Alternative Mediterranean Diet score (n = 18,533 participants).
CharacteristicsOverall
n = 18,533		aMED
Q1Q2Q3Q4Q5
aMED score, mean ± SD4.7 ± 1.82.4 ± 0.84.0 ± 0.05.0 ± 0.06.0 ± 0.07.4 ± 0.6
Physical activity, MET-hrs/wk mean ± SD20.0 ± 23.114.7 ± 19.918.3 ± 21.720.6 ± 23.322.7 ± 23.826.6 ± 26.1
Age, yr mean ± SD56.2 ± 12.053.1 ± 11.955.4 ± 11.856.8 ± 11.958.1 ± 11.959.1 ± 11.3
Years of diagnosis, n (%)
<5 yrs8099 (43.7)2169 (44.9)1512 (44.6)1605 (43.8)1427 (43.2)1386 (41.7)
5-<10 yrs4347 (23.5)1143 (22.6)826 (24.0)868 (24.0)732 (22.7)778 (24.1)
≥10 yrs6087 (32.8)1649 (32.6)1078 (31.3)1165 (32.2)1097 (34.1)1098 (34.1)
Age of diagnosis, yr mean ± SD70.0 ± 11.965.0 ± 11.967.1 ± 11.868.3 ± 12.069.4 ± 11.970.3 ± 11.5
Baseline BMI, n(%)
<18 kg/m2 874 (4.7)217 (4.8)155 (4.7)189 (5.1)166 (4.9)147 (4.1)
18-<22.5 kg/m25957 (32.1)1563 (30.3)1047 (30.3)1122 (31.1)1065 (33.6)1160 (37.3)
22.5-<25 kg/m24092 (22.1)1010 (20.2)743 (21.9)804 (22.1)730 (22.2)805 (24.3)
25-<30 kg/m24827 (26.1)1260 (26.2)918 (27.0)994 (27.1)851 (25.6)804 (23.6)
≥30 kg/m22783 (15.0)911 (18.5)553 (16.1)529 (14.6)444 (13.7)346 (10.7)
Alcohol intake, %
Never drinker5739 (31.0)1969 (39.8)1148 (33.7)1135 (31.1)872 (26.5)615 (18.3)
<15 g/day9089 (49.0)2109 (41.0)1600 (46.5)1795 (49.6)1667 (51.9)1918 (60.2)
≥15 g/day3705 (20.0)883 (19.2)668 (19.8)708 (19.3)717 (21.6)729 (21.5)
Race/ethnicity, %
White 16,649 (89.8)4354 (88.6)3071 (90.0)3294 (90.5)2946 (90.1)2984 (91.2)
Other race/unspecified1884 (10.2)607 (11.4)345 (10.0)344 (9.5)310 (9.9)278 (8.8)
Menopausal status and HT use, %
Premenopausal5181 (30.0)1801 (28.2)1038 (28.8)951 (27.7)743 (27.3)648 (27.3)
Peri-/postmenopausal, never use HT2587 (14.0)654 (16.1)434 (13.3)553 (14.7)479 (13.3)467 (12.4)
Peri-/postmenopausal, past use HT1442 (7.8)303 (7.7)248 (7.7)311 (8.2)290 (7.9)290 (7.4)
Peri-/postmenopausal, current use HT6433 (34.7)1443 (32.7)1136 (34.0)1272 (34.1)1228 (35.4)1354 (36.9)
Peri-/postmenopausal, unknown HT use902 (4.9)196 (5.0)188 (5.7)171 (4.5)165 (4.6)182 (4.8)
Unknown menopausal status1988 (10.7)564 (10.4)372 (10.4)380 (10.7)351 (11.5)321 (11.2)
Smoking status, %
Smokers7349 (39.6)1858 (39.8)1363 (40.2)1459 (39.8)1303 (39.3)1366 (40.2)
Non-smokers/unknown11,184 (60.4)3103 (60.2)2053 (59.8)2179 (60.2)1953 (60.7)1896 (59.8)
History of diabetes, %478 (2.6)134 (3.0)84 (2.55)99 (2.7)88 (2.6)73 (2.0)
History of hypertension, %3587 (19.4)938 (21.5)648 (19.5)715 (19.2)657 (18.8)639 (17.3)
Daily vitamin use, %12,474 (67.3)2909 (60.3)2241 (65.9)2473 (67.7)2331 (71.1)2520 (76.3)
Total energy intake, kcal/d mean ± SD1561.6 ± 499.61382.2 ± 454.41519.1 ± 489.71566.2 ± 497.01687.2 ± 516.61762.7 ± 487.0
1 All variables except for age and age of diagnosis are age-standardized. aMED = Alternative Mediterranean Diet, SD = standard deviation, Q = quintile, BMI = body mass index, HT = hormonal therapy.
Table
Table 2. Hazard ratio (95% CIs) of CVD mortality associated with pre-cancer diagnosis Alternative Mediterranean Diet scores and physical activity levels among female cancer survivors in the California Teachers Study cohort (n = 18,533).
Table 2. Hazard ratio (95% CIs) of CVD mortality associated with pre-cancer diagnosis Alternative Mediterranean Diet scores and physical activity levels among female cancer survivors in the California Teachers Study cohort (n = 18,533).
aMED,
Quintiles
(Score Range)		CasesPerson-YearsModel 1Model 2Model 3
Q1 (<4)19837,1931.00
(reference)		1.00
(reference)		1.00
(reference)
Q2 (4-<5)14725,1530.87
(0.71, 1.08)		0.87
(0.70, 1.08)		0.88
(0.71, 1.09)
Q3 (5-<6)17926,9860.86
(0.71, 1.06)		0.87
(0.71, 1.06)		0.89
(0.73, 1.10)
Q4 (6-<7)20024,6320.90
(0.72, 1.10)		0.90
(0.71, 1.10)		0.93
(0.76, 1.15)
Q5 (≥7)19124,7780.84
(0.69, 1.03)		0.83
(0.67, 1.03)		0.89
(0.72, 1.11)
Ptrend = 0.16Ptrend = 0.16Ptrend = 0.47
Physical activity in recent 3 years prior to baseline, MET-hrs/wk,
Quartiles		CasesPerson-YearsModel 1Model 2Model 4
Q1 (<3.5)29234,1621.00 (reference)1.00 (reference)1.00 (reference)
Q2 (3.5-<13.5)20734,2040.86
(0.72, 1.02)		0.86
(0.72, 1.03)		0.87
(0.72, 1.04)
Q3 (13.5-<27.5)20734,1770.77
(0.65, 0.93)		0.79
(0.66, 0.94)		0.80
(0.67, 0.96)
Q4 (≥27.5)20936,1990.73
(0.61, 0.87)		0.73
(0.61, 0.87)		0.74
(0.61, 0.88)
Ptrend < 0.001Ptrend < 0.001Ptrend = 0.0014
Model 1: Adjusted for time interval from questionnaire 1 to cancer diagnosis date, age at cancer diagnosis. Model 2: Adjusted for time interval from questionnaire 1 to cancer diagnosis date, age at cancer diagnosis, race, smoking status, menopausal status and hormone use, total energy intake, and daily vitamin use. Model 3: Adjusted for physical activity + covariates included in Model 2. Model 4: Adjusted for aMED + covariates included in Model 2. CI = confidence interval, CVD = cardiovascular disease, aMED = Alternative Mediterranean Diet, Q = quintile for diet and quartile for physical activity.
Table
Table 3. Hazard ratios (95% CIs) of CVD mortality associated with pre-cancer diagnosis Alternative Mediterranean Diet scores and physical activity levels after adjustment for post-diagnosis levels among female cancer survivors with available data at least 1 year after cancer diagnosis in the California Teachers Study cohort (n = 3327).
Table 3. Hazard ratios (95% CIs) of CVD mortality associated with pre-cancer diagnosis Alternative Mediterranean Diet scores and physical activity levels after adjustment for post-diagnosis levels among female cancer survivors with available data at least 1 year after cancer diagnosis in the California Teachers Study cohort (n = 3327).
aMED, TertilesCasesPerson-YearsModel 1Model 2Model 3
<43912,6711.00 (reference)1.00 (reference)1.00 (reference)
4-<65617,9850.76
(0.50, 1.16)		0.78
(0.51, 1.19)		0.83
(0.54, 1.28)
≥68617,8690.84
(0.56, 1.26)		0.87
(0.58, 1.33)		1.07
(0.69, 1.65)
Ptrend = 0.54Ptrend = 0.68Ptrend = 0.62
Physical activity in recent 3 years prior to baseline, MET-hrs/wk,
Tertiles		CasesPerson-YearsModel 1Model 4Model 5
<6.257415,3651.00 (reference)1.00 (reference)1.00 (reference)
6.25-<22.54815,7240.74
(0.51, 1.08)		0.76
(0.52, 1.10)		0.76
(0.52, 1.11)
≥22.55917,4260.79
(0.56, 1.12)		0.83
(0.57, 1.19)		0.84
(0.56, 1.25)
Ptrend = 0.25Ptrend = 0.38Ptrend = 0.44
Model 1: Adjusted for interval from questionnaire 1 to cancer diagnosis date, age at cancer diagnosis, race, smoking status, menopausal status and hormone use, total energy intake, and daily vitamin use. Model 2: Additionally adjusted for physical activity before cancer diagnosis. Model 3: Additionally adjusted for physical activity before cancer diagnosis + aMED after cancer diagnosis. Model 4: Additionally adjusted for aMED before cancer diagnosis. Model 5: Additionally adjusted for aMED before cancer diagnosis + physical activity after diagnosis. CI = confidence interval, CVD = cardiovascular disease, aMED = Alternative Mediterranean Diet.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Weikart, D.; Lin, D.; Dhingra, R.; Al-Shaar, L.; Sturgeon, K. Pre-Diagnosis Diet and Physical Activity and Risk of Cardiovascular Disease Mortality among Female Cancer Survivors. Cancers 2022, 14, 3096. https://doi.org/10.3390/cancers14133096

AMA Style

Weikart D, Lin D, Dhingra R, Al-Shaar L, Sturgeon K. Pre-Diagnosis Diet and Physical Activity and Risk of Cardiovascular Disease Mortality among Female Cancer Survivors. Cancers. 2022; 14(13):3096. https://doi.org/10.3390/cancers14133096

Chicago/Turabian Style

Weikart, Daphne, Dan Lin, Radha Dhingra, Laila Al-Shaar, and Kathleen Sturgeon. 2022. "Pre-Diagnosis Diet and Physical Activity and Risk of Cardiovascular Disease Mortality among Female Cancer Survivors" Cancers 14, no. 13: 3096. https://doi.org/10.3390/cancers14133096

APA Style

Weikart, D., Lin, D., Dhingra, R., Al-Shaar, L., & Sturgeon, K. (2022). Pre-Diagnosis Diet and Physical Activity and Risk of Cardiovascular Disease Mortality among Female Cancer Survivors. Cancers, 14(13), 3096. https://doi.org/10.3390/cancers14133096

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop